FDA clears first OTC continuous blood glucose monitor
The U.S. Food and Drug Administration on Tuesday approved the country's first over-the-counter continuous glucose monitor for type 2 diabetes.
Mar 6, 2024
0
3
The U.S. Food and Drug Administration on Tuesday approved the country's first over-the-counter continuous glucose monitor for type 2 diabetes.
Mar 6, 2024
0
3
Canada on Thursday unveiled a framework for a universal drug plan that, once fully implemented, would mark the biggest expansion of its publicly funded health care system in decades.
Mar 1, 2024
0
0
Research targeting the insulin-inhibitory receptor, or inceptor, unveils promising avenues for beta cell protection, offering hope for causal diabetes therapy.
Feb 28, 2024
0
15
Diabetic patients who take anti-diabetic drugs—known as glitazones—long term had a lower risk of primary and secondary brain cancer compared with diabetic patients on other medications, new research led by the University ...
Feb 22, 2024
0
9
Experts at the Smidt Heart Institute at Cedars-Sinai who have studied progress made over decades of research say there's still a long way to go before medical science fully understands how heart disease is different in women ...
Feb 19, 2024
0
0
A new approach to treating neuropathic pain is making a key step forward thanks to researchers at The University of Texas at Austin.
Jan 30, 2024
0
74
Wegovy, Ozempic and Mounjaro are weight loss and diabetes drugs that have made quite a splash in health news. They target regulatory pathways involved in both obesity and diabetes and are widely considered breakthroughs for ...
Jan 17, 2024
0
2
A French appeals court on Wednesday ordered pharmaceutical firm Servier to pay more than $460 million in damages over a scandal involving a diabetes drug linked to hundreds of deaths.
Dec 20, 2023
0
0
Most patients with type 2 diabetes will end up needing to add a second-line medication after metformin—the go-to primary drug for glucose management—to control their blood sugar levels. But adherence to these second-line ...
Dec 12, 2023
0
10
Wegovy, Mounjaro, Ozempic... These new drugs drawing such intense attention have raised the hopes of millions around the world suffering from diabetes or obesity. But what are they, how are they used and who makes them?
Dec 4, 2023
0
0